HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H Miyashita Selected Research

T-3775440

9/2017Synergistic anti-AML effects of the LSD1 inhibitor T-3775440 and the NEDD8-activating enzyme inhibitor pevonedistat via transdifferentiation and DNA rereplication.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


H Miyashita Research Topics

Disease

4Neoplasms (Cancer)
01/2018 - 08/2000
3Ischemia
02/2000 - 01/2000
2Transient Ischemic Attack
09/2001 - 02/2000
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
09/2017
1Body Weight (Weight, Body)
03/2011
1Obesity
03/2011
1Sexually Transmitted Diseases (Sexually Transmitted Disease)
10/2003
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2003
1Philadelphia Chromosome
10/2003
1Rheumatoid Arthritis
10/2003
1Aortic Dissection
02/2002
1Aneurysm (Aneurysms)
02/2002
1Aortic Arch Aneurysm
02/2002
1Reperfusion Injury
09/2001
1Non-Hodgkin Lymphoma (Lymphosarcoma)
09/2001
1Cicatrix (Scar)
09/2001
1Ulcer
09/2001
1Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
09/2001
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
09/2001
1Brain Ischemia (Cerebral Ischemia)
09/2001
1Stomach Neoplasms (Stomach Cancer)
04/2001
1Unstable Angina
04/2001
1Colonic Neoplasms (Colon Cancer)
08/2000
1Fever (Fevers)
08/2000
1Multiple Myeloma
08/2000
1Pain (Aches)
08/2000
1Hypercalcemia (Milk Alkali Syndrome)
08/2000
1Thrombocytopenia (Thrombopenia)
08/2000
1Anemia
08/2000
1Thrombosis (Thrombus)
05/2000
1Cerebral Hemorrhage
05/2000
1Infarction (Infarctions)
05/2000
1Heart Failure
03/2000
1Cardiomegaly (Heart Hypertrophy)
03/2000
1Stroke (Strokes)
02/2000
1Hyperglycemia
01/2000

Drug/Important Bio-Agent (IBA)

2Glutamic Acid (Glutamate)FDA Link
09/2001 - 01/2000
2TaurineFDA Link
02/2000 - 01/2000
1Surface Antigens (Surface Antigen)IBA
01/2018
1Cetuximab (Erbitux)FDA Link
01/2018
1Indicators and Reagents (Reagents)IBA
01/2018
1pevonedistatIBA
09/2017
1T-3775440IBA
09/2017
1Nonesterified Fatty Acids (NEFA)IBA
03/2011
1geniposidic acidIBA
03/2011
1asperulosideIBA
03/2011
1Antihypertensive Agents (Antihypertensives)IBA
03/2011
1Chlorogenic AcidIBA
03/2011
1CholesterolIBA
03/2011
1Triglycerides (Triacylglycerol)IBA
03/2011
1Polystyrenes (Polystyrene)IBA
03/2011
1C-Reactive ProteinIBA
10/2003
1Imatinib Mesylate (Gleevec)FDA Link
10/2003
1Excitatory Amino Acid AntagonistsIBA
09/2001
14- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA
08/2000
1NADPH Oxidases (NAD(P)H oxidase)IBA
08/2000
1A-Form DNA (A-DNA)IBA
08/2000
1EnzymesIBA
08/2000
1Messenger RNA (mRNA)IBA
08/2000
1Immunoglobulin A (IgA)IBA
08/2000
1Proteins (Proteins, Gene)FDA Link
08/2000
1Neuroprotective AgentsIBA
05/2000
1Topiramate (Topamax)FDA LinkGeneric
05/2000
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
05/2000
1Fibrinolytic Agents (Antithrombotic Agents)IBA
05/2000
1Angiotensin IIBA
03/2000
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
03/2000
1Angiotensin Receptors (Angiotensin II Receptor)IBA
03/2000
1Ethanol (Ethyl Alcohol)IBA
02/2000
1Glycine (Aminoacetic Acid)FDA LinkGeneric
01/2000
1Glucose (Dextrose)FDA LinkGeneric
01/2000
1Alanine (L-Alanine)FDA Link
01/2000
1Excitatory Amino AcidsIBA
01/2000
1Serine (L-Serine)FDA Link
01/2000
1Glutamine (L-Glutamine)FDA Link
01/2000

Therapy/Procedure

2Therapeutics
08/2000 - 05/2000
1Drug Therapy (Chemotherapy)
01/2018
1Thoracotomy
02/2002
1Radiotherapy
09/2001
1Overlapping Surgery
04/2001